Our NIH BPN grant was selected for funding!

Feb 1, 2022

1 min read

Our grant application (Ali, Lemmon, Bixby, Lee, Arizala) to the Blueprint Neurotherapeutics network was selected for funding! The goal of this proposal is to generate a therapeutic candidate (spinal cord injury) for clinical development.

Recent Posts

See All

New Foundation Funding

We have received a generous grant from the Hearst Foundation to support preclinical and IND-enabling studies on our drug candidate for spinal cord injury, TMP-316.

Our NCI RO1 received a 1.0 percentile score!!!

Our NCI R01 (Schatz, Ali) received a 1 percentile score. This grant aims to study the essential role of the cyclin-G associated kinase...

New DoD Funding

The Zeier and Ali labs received a DoD Therapeutic Idea Award. The goal of the project is to evaluate whether the spinal cord injury drug...

The Ali Lab at the University of Miami

Our NIH BPN grant was selected for funding!

Recent Posts

Comments